Quantum Surgical, an innovative surgical robotic company which is developing a unique mini-invasive surgery solution dedicated to liver cancer treatment, announces that it has been granted €200 000 by the Occitanie Region.
This investment grant financed by the Occitanie Region as part of a plan for local businesses, labeled “Pass Rebond Occitanie”, aims to support economic recovery following the Covid-19 health crisis.
This grant will enable the company to purchase and integrate an information system (Enterprise Resource Planning – ERP), prior to its first product sales dedicated to minimally invasive liver cancer treatment.
“We are extremely grateful for the support received from the Occitanie region, especially with the current Health crisis. This grant will help us pursuing our robotic platform development, which is scheduled to be commercially launched in 2021. “said Christophe Sibillin, C.F.O of Quantum Surgical.